GPP
FLNA

Great Point Partners’s Filana Therapeutics FLNA Stock Holding History

Great Point Partners’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-259,698
Closed -$7.11M – 35
2014
Q3 		$7.11M Buy
259,698
+17,661
+7% +$537K 3.05% 16
2014
Q2 		$9.74M Sell
242,037
-84,717
-26% -$3.13M 4.33% 8
2014
Q1 		$12.6M Sell
326,754
-72,916
-18% -$2.57M 6.57% 3
2013
Q4 		$13.6M Sell
399,670
-16,166
-4% -$429K 9.6% 2
2013
Q3 		$7.92M Buy
+415,836
New +$7.27M 5.49% 6

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Great Point Partners's FLNA Position: Q4 2014 in Review

Great Point Partners sold out of Filana Therapeutics (FLNA) in Q4 2014, closing a stake of 259,698 shares — an estimated $7.11M sold.

Great Point Partners first reported a position in FLNA in Q3 2013 and held it in 5 quarters. The position peaked at $13.6M in Q4 2013. 66 funds tracked by Wall St. Rank hold FLNA as of Q4 2014.

  • Great Point Partners reported no remaining Filana Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Great Point Partners sold 259,698 Filana Therapeutics shares in Q4 2014, an estimated $7.11M.
  • Great Point Partners first reported a position in Filana Therapeutics in Q3 2013 and held it in 5 quarters.
  • Great Point Partners's Filana Therapeutics position peaked at $13.6M in Q4 2013.
  • 66 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2014.

Based on Great Point Partners's 13F filing for Q4 2014, filed 17 Feb 2015.